Colistimethate, a potent antimicrobial compound, holds immense value within the biomedical industry for the treatment of severe infections. Specifically developed to combat multidrug-resistant Gram-negative bacteria, especially the formidable Pseudomonas aeruginosa, it operates within the realm of polymyxin antibiotics. By intricately disrupting the bacterial cell membrane, Colistimethate displays its efficacy. With the flexibility of three administration routes - inhalation, injection, or nebulization - this product epitomizes versatility, offering a myriad of therapeutic choices to tackle a diverse range of drug-resistant infections effectively.
CAT No: R1998
CAS No:12705-41-8
Chemical Name:pentasodium;[2-[17-(1-hydroxyethyl)-22-[[2-[[3-hydroxy-2-[[2-(6-methyloctanoylamino)-4-(sulfonatomethylamino)butanoyl]amino]butanoyl]amino]-4-(sulfonatomethylamino)butanoyl]amino]-5,8-bis(2-methylpropyl)-3,6,9,12,15,18,23-heptaoxo-11,14-bis[2-(sulfonatomethylamino)ethyl]-1,4,7,10,13,16,19-heptazacyclotricos-2-yl]ethylamino]methanesulfonate
Colistimethate is a polymyxin-class antibiotic prodrug notable for its polyanionic structure and unique mechanism of action targeting Gram-negative bacterial membranes. As a cyclic polypeptide derivative, it is of significant interest in microbiological, biochemical, and pharmaceutical research due to its ability to disrupt bacterial cell envelope integrity. Colistimethate is hydrolyzed to colistin in aqueous environments, enabling it to interact with lipopolysaccharides and phospholipids in the outer membrane of susceptible bacteria. Its biochemical relevance extends to studies of membrane permeability, resistance mechanisms, and the development of novel antimicrobial strategies, making it a valuable tool for researchers investigating multidrug-resistant bacterial pathogens and the molecular basis of antibiotic action.
Antimicrobial Mechanism Studies: Researchers utilize colistimethate to investigate the molecular mechanisms underlying polymyxin-mediated bacterial killing. Its capacity to bind the lipid A component of lipopolysaccharides facilitates studies on membrane disruption, ion leakage, and cell lysis in Gram-negative organisms. By employing this compound in in vitro assays, scientists can dissect the sequence of events leading to bacterial death, thereby gaining insights into the structure-activity relationships that govern polymyxin efficacy and specificity.
Antibiotic Resistance Research: Colistimethate serves as a critical tool in elucidating the genetic and biochemical foundations of resistance in clinically significant bacteria, such as Pseudomonas aeruginosa, Acinetobacter baumannii, and Enterobacteriaceae. Its use in laboratory evolution experiments, screening of resistance determinants, and functional genomics enables the identification of mutations and adaptive responses that confer reduced susceptibility. These studies are pivotal for understanding the evolution of resistance and for informing the design of next-generation antimicrobial agents.
Pharmacokinetic and Metabolic Profiling: The prodrug nature of colistimethate makes it an ideal candidate for pharmacokinetic and metabolic investigations in preclinical models. Researchers employ it to characterize hydrolysis rates, bioactivation to colistin, and subsequent distribution, metabolism, and excretion pathways. Such studies are essential for optimizing dosing regimens, evaluating drug stability, and predicting the in vivo behavior of polymyxin derivatives, thereby supporting rational drug development and formulation efforts.
Analytical Method Development: Analytical chemists and quality control laboratories frequently use colistimethate as a reference standard or analyte for the development and validation of quantitative assays. High-performance liquid chromatography (HPLC), mass spectrometry, and related techniques rely on this compound to establish calibration curves, assess matrix effects, and monitor degradation products. These analytical applications are crucial for ensuring the reliability and reproducibility of research involving polymyxin antibiotics.
Microbial Susceptibility Testing: Laboratories engaged in antimicrobial susceptibility testing employ colistimethate to determine the minimum inhibitory concentrations (MICs) of Gram-negative bacterial isolates. Its inclusion in standardized broth microdilution or agar dilution protocols allows for the assessment of bacterial sensitivity patterns, detection of emerging resistance, and evaluation of combination therapies. These susceptibility data inform both basic research and the development of new strategies to combat multidrug-resistant infections.
By supporting a broad spectrum of research applications, colistimethate remains a cornerstone compound for the study of polymyxin antibiotics, bacterial membrane biology, and antimicrobial resistance mechanisms. Its multifaceted utility across microbiological, biochemical, and analytical domains underscores its ongoing importance in advancing scientific understanding and innovation in the field of antibacterial research.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More